84
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Comparison of guar gum from different sources for the preparation of prolonged-release or colon-specific dosage forms

&
Pages 271-277 | Received 07 Aug 2008, Accepted 25 Sep 2008, Published online: 01 Jun 2009

References

  • Yu K, Wong D, Parasrampuria J, Friend D. Guar gum. In: Florey AT, ed. Analytical Profiles of Drug Substances and Excipients. Vol. 24. California: Academic Press; 1996:243–276.
  • Elsabbagh HM, Sakr AM, Abd-Elhadi S. Effect of guar gum on the dissolution rate of ephedrine hydrochloride and sulphadimidine tablets. Pharmazie. 1978;33:730–731.
  • Baweja JM, Mısra AN. Modified guar gum as film former. Pharmazie. 1999;54:678–681.
  • Coviello T, Matricardi P, Marianecci C, Alhaique F. Polysaccharide hydrogels for modified release formulations. J Control Rel. 2007;119:5–24.
  • George M, Abraham TE. pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs. Int J Pharm. 2007;335:123–129.
  • Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery. Int J Pharm. 2001;24:19–38.
  • Altaf SA, Yu K, Parasrampuria J, Friend DR. Guar gum-based sustained release diltiazem. Pharm Res. 1998;15:1196–1201.
  • Jain NK, Kulkarni K, Talwar N. Controlled-release tablet formulation of isoniazid. Pharmazie. 1992;47:277–278.
  • Krishnaiah YSR, Karthikeyan RS, Gouri Sankar V, Satyanarayana V. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride. J Control Rel. 2002;81:45–56.
  • Krishnaiah YSR, Satyanarayana S, Rama Prasad YV, Rao Narasimha S. Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy human volunteers. J Control Rel. 1998;55:245–252.
  • Krishnaiah YSR, Veer Raju P, Dinesh Kumar B, Bhaskar P, Satyanarayana V. Development of colon targeted drug delivery systems for mebendazole. J Control Rel. 2001;77:87–95.
  • Krishnaiah YSR, Bhaskar Reddy PR, Satyanarayana V, Karthikeyan RS. Studies on the development of oral colon targeted drug delivery systems for metronidazole in the treatment of amoebiasis. Int J Pharm. 2002;236:43–55.
  • Tuğcu-Demiröz F, Acartürk F, Takka S, Konuş-Boyunağa Ö. In-vitro and in-vivo evaluation of mesalazine-guar gum matrix tablets for colonic drug delivery. J Drug Target. 2004;12:105–112.
  • Tuğcu-Demiröz F, Acartürk F, Takka S. Investigation of colon-specific dosage forms of ondansetron prepared with natural polymers. Pharmazie. 2006;61:916–919.
  • Krishnaiah YSR, Satyanarayana S, Rama Prasad YV, Rao Narasimha S. Evaluation of guar gum as a compression coat for drug targeting to colon. Int J Pharm. 1998;171:137–146.
  • Sinha VR, Mittal BR, Bhutani KK, Kumria R. Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int J Pharm. 2004;269:101–108.
  • Guo J, Skinner GW, Harcum WW, Barnum PE. Pharmaceutical applications of naturally occuring water-soluble polymers. PSTT. 1998;1:254–261.
  • Mastiholimath VS, Dandagi PM, Samata Jain S, Gadad AP, Kulkarni AR. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. Int J Pharm. 2007;328:49–56.
  • Cohen JL. Theophylline. In: Florey AT, ed. The Analytical Profiles of Drug Substances. Vol. 4. California: Academic Press; 1975:468–493.
  • Osterwald HP. Pharmaceutic development: Mesalazine. Scand J Gastroenter. 1990;25:43–46.
  • Steed KP, Hooper G, Monti N, Benedetti MS, Fornasini G, Wilding IR. The use of pharmacoscintigraphy to focus the development strategy for a novel 5-ASA colon targeting system (TIME CLOCK® system). J Control Rel. 1997;49:115–122.
  • Watts PJ, Illum L. Colonic drug delivery. Drug Develop Ind Pharm. 1997;23:893–913.
  • Basit AW. Advances in colonic drug delivery. Drugs. 2005;65:1991–2007.
  • Casas JA, Mohedano AF. Viscosity of guar gum and xanthan/guar gum mixture solutions. J Sci Food Agric. 2000;80:1722–1727.
  • Vemuri S. Flow and consistency index dependence of pseudoplastic guar gum solutions. Drug Develop Ind Pharm. 1991;17:1731–1751.
  • Dürig T, Fassihi R. Guar-based monolithic matrix systems: effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics. J Control Rel. 2002;80:45–56.
  • Khullar P, Khar RK, Agarwal SP. Evaluation of guar gum in the preparation of sustained-release matrix tablets. Drug Develop Ind Pharm. 1998;24:1095–1099.
  • Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110–111.
  • Altaf SA, Wong D, Gebert M, Larrabee S, Yu K, Friend DR. Drug release profiles of swellable hydrocolloid formulations: USP apparatus 2 versus apparatus 3, in vitro correlation. Pharm Technol. 1998;3:97–101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.